** JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | 19/02 | 4,24% |
| * JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | 19/02 | 4,65% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | 19/02 | 6,16% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | 19/02 | 4,24% |
| * JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | 19/02 | 4,65% |
| ** JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | 19/02 | 4,21% |
| * JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | 19/02 | 4,64% |
| * JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | 19/02 | 4,64% |
| ** JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | 19/02 | 4,02% |
| * JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | 19/02 | 4,44% |
| ** JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | 19/02 | 4,24% |
| * JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | 19/02 | 4,66% |
| ** JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | 19/02 | 4,46% |
| ** JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | 19/02 | 4,22% |
| **** JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | 19/02 | 7,37% |
| **** JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | 19/02 | 7,56% |
| ** JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | 19/02 | 7,36% |
| * JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | 19/02 | 5,89% |
| **** JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | 19/02 | 7,48% |
| *** JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | 19/02 | 7,27% |
